| Hans-Günter Meyer-Thompson | Hepatitiden
Australien. World first program aims to eliminate hepatitis C among people who inject drugs
Australien. World first program aims to eliminate hepatitis C among people who inject drugs
The inaugural symposium of the world first research program ASCEND was held at UNSW Sydney on Monday, 13 May.
ASCEND is designed to improve access to hepatitis C treatment for people who inject drugs and potentially eliminate the virus among this population.
The five-year research program is being run jointly by The National Drug and Alcohol Research Centre (NDARC) and The Kirby Institute at UNSW Sydney and is funded by a $9 million National Health and Medical Research Centre (NHMRC) program grant which commenced in January 2019. (University of South Wales, Sydney; NDARC – National Drug and Alcohol Research Center, Australien, 28.05.2019)